Assistance Listing 93.350
National Center for Advancing Translational Sciences
National Institutes of Health · Department of Health and Human Services
The verdict for a small nonprofit
A realistic target for an established nonprofit. 25% of awards go to first-time applicants and nonprofits win 21%.
Based on 341 new awards in FY2023–25. Organizations under $1M in revenue won 0% of the awards that went to nonprofits. The median award is $419,375. Expect about 219 days between posting and deadline.
- First-time winners
- 25%
- of new awards, last 3 FYs
- Nonprofit share
- 21%
- 50% higher ed · 0% gov't
- Under-$1M orgs
- 0%
- of nonprofit awards
- Median award
- $419K
- $163K – $2.1M middle half
- New awards, FY2025
- 101
- $193M committed to them
- Usually posts
- Dec
- rolling · 219-day window
Open right now under this program
36 opportunities · from Grants.gov, checked every 10 minutes
Who won in FY2025
Largest recipients by dollars. From USAspending.
| Recipient | Type | State | Awards | Awarded |
|---|---|---|---|---|
| Gordon Research Conferences | Nonprofit | RI | 21 | $420,480 |
| Keystone Symposia on Molecular and Cellular Biology | Nonprofit | CO | 16 | $257,050 |
| The Johns Hopkins University | Higher ed | MD | 12 | $59,246,744 |
| Regents of the University of Michigan | Higher ed | MI | 10 | $62,063,568 |
| University of North Carolina at Chapel Hill | Higher ed | NC | 10 | $58,417,055 |
| The Children'S Hospital of Philadelphia | Nonprofit | PA | 10 | $9,636,999 |
| Icahn School of Medicine at Mount Sinai | Higher ed | NY | 9 | $68,306,111 |
| Ohio State University, the | Higher ed | OH | 9 | $27,376,888 |
| Virginia Commonwealth University | Higher ed | VA | 9 | $25,449,544 |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Other | PA | 8 | $41,620,222 |
New awards by fiscal year
Awards first made in each fiscal year; dollars are the total committed to that year's new awards over their life.
| FY | New awards | Committed | Median | Middle half |
|---|---|---|---|---|
| 2021 | 134 | $219M | $419K | $159K – $1.4M |
| 2022 | 84 | $152M | $342K | $156K – $1.5M |
| 2023 | 122 | $586M | $363K | $156K – $3.0M |
| 2024 | 118 | $306M | $431K | $169K – $2.1M |
| 2025 | 101 | $193M | $419K | $163K – $2.1M |
Past rounds
Every announcement under this listing that Grants.gov still lists. Use it to plan next year.
| Posted | Closed | Window | Announcement |
|---|---|---|---|
| 2026-07-20 | forecast | — | PAR-28-002 · Clinical and Translational Science Award |
| 2026-07-20 | forecast | — | PAR-28-005 · Limited Competition: Research Education Program for the Clinical and Translational Science Awards Program |
| 2026-07-20 | forecast | — | PAR-28-006 · Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science |
| 2026-07-20 | forecast | — | PAR-28-007 · The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network |
| 2026-07-20 | forecast | — | PAR-28-003 · Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards Program |
| 2026-07-20 | forecast | — | PAR-28-008 · Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award |
| 2026-07-20 | forecast | — | PAR-28-004 · Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant for the Clinical and Translational Science Awards Program |
| 2026-05-28 | 2027-04-05 | 312 d | PA-27-102 · NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) |
| 2026-05-28 | 2029-04-05 | 1043 d | PA-27-101 · NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) |
| 2026-05-28 | 2027-04-05 | 312 d | PA-27-100 · NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) |
| 2026-05-28 | 2029-04-05 | 1043 d | PAR-27-098 · SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) |
| 2026-05-27 | forecast | — | PAR-27-039 · Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) |
| 2026-05-27 | forecast | — | PAR-27-040 · Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) |
| 2026-05-13 | 2028-06-15 | 764 d | RFA-OD-27-005 · INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) |
| 2026-05-12 | 2028-06-15 | 765 d | RFA-OD-27-004 · INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) |
| 2026-03-09 | — | — | PAR-26-128 · Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trial Optional) |
| 2026-02-18 | forecast | — | PAR-26-123 · Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (Clinical Trial Optional) |
| 2026-01-20 | 2029-05-07 | 1203 d | PA-26-002 · NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) |
| 2025-11-26 | 2028-11-30 | 1100 d | PA-26-001 · Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
| 2025-09-29 | forecast | — | RFA-TR-26-002 · Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Network (ERN) (Clinical Trial Not Allowed) |
| 2025-09-29 | forecast | — | RFA-TR-25-016 · Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed) |
| 2025-09-29 | — | — | RFA-TR-26-001 · Screening for Conditions by Electronic Nose Technology (SCENT III) (Clinical Trial Not Allowed) |
| 2025-09-22 | 2028-07-20 | 1032 d | PAR-25-450 · Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
| 2025-06-27 | forecast | — | FOR-TR-27-002 · Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe) |
| 2025-06-27 | forecast | — | FOR-TR-27-003 · Selective Precision Targeting (SPoT) |
| 2025-06-17 | 2028-02-17 | 975 d | PAR-25-442 · Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) |
| 2025-06-05 | 2025-12-09 | 187 d | PAR-25-438 · Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
| 2024-12-19 | 2027-09-28 | 1013 d | PAR-25-194 · Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) |
| 2024-12-19 | 2027-09-28 | 1013 d | PAR-25-195 · Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) |
| 2024-12-18 | 2028-01-07 | 1115 d | PA-25-301 · NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
| 2024-12-18 | 2028-01-07 | 1115 d | PA-25-304 · NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) |
| 2024-12-11 | 2026-10-19 | 677 d | PAR-25-155 · Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) |
| 2024-12-11 | 2026-07-16 | 582 d | PAR-25-154 · HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) |
| 2024-12-11 | 2027-10-19 | 1042 d | PAR-25-296 · Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
| 2024-12-10 | 2026-09-28 | 657 d | PAR-25-156 · Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional) |
| 2024-12-10 | 2026-06-18 | 555 d | PAR-25-157 · Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) |
| 2024-12-10 | 2027-09-28 | 1022 d | PAR-25-196 · Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) |
| 2024-12-09 | 2027-05-28 | 900 d | PAR-25-197 · Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) |
| 2024-12-06 | 2027-07-02 | 938 d | RFA-TR-25-002 · Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) |
| 2024-11-20 | 2025-12-09 | 384 d | PAR-25-217 · Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
Common questions
How hard is it to win a grant under 93.350?
A realistic target for an established nonprofit. 25% of awards go to first-time applicants and nonprofits win 21%. Based on 341 new awards in FY2023–25. Organizations under $1M in revenue won 0% of the awards that went to nonprofits. The median award is $419,375. Expect about 219 days between posting and deadline.
How much does National Center for Advancing Translational Sciences award?
In FY2025 the median new award was $419K; the middle half ran from $163K to $2.1M. 101 new awards were made, with $193M committed to them.
When does 93.350 usually post?
Over the last several years, new rounds most often posted in Dec with about 219 days to apply. The most recent round posted May 28, 2026.
Who runs this program?
Department of Health and Human Services (National Institutes of Health). Assistance Listing 93.350 on SAM.gov describes the authorizing statute and standard terms.
Sources: USAspending FY2021–25 award archive (2026-10-06); Grants.gov Search2 (fetched 2026-10-28); IRS EO BMF (fetched 2026-10-28). Award counts are new awards by fiscal year of first action. Shares are computed from award counts, not dollars; the under-$1M share covers the 73% of nonprofit awards that matched an IRS revenue record. Recipient type comes from the award record's business-type codes. Always confirm details in the official announcement.